-- 根据广州白云山药业（港交所代码：0874，沪交所代码：600332）周一在香港联交所提交的公告，该公司第一季度归属于股东的净利润同比下降2.1%至17.8亿元人民币，而去年同期为18.2亿元人民币。 每股收益为1.097元人民币，而去年同期为1.120元人民币。 营业利润同比增长3.6%至233亿元人民币，而去年同期为225亿元人民币。 周二早盘，该公司在香港上市的股票上涨2%，在上海上市的股票上涨3%。
Related Articles
Asia
Raytron Tech's Q1 Profit Surges 228%, Revenue Jumps 71%; Shares Up 5%
Raytron Technology's (SHA:688002) net profit attributable to shareholders in the first quarter surged 228% to 478.7 million yuan from 145.8 million yuan a year earlier, according to a Shanghai bourse filing on Tuesday.Earnings per share soared 211% year on year to 0.98 yuan from 0.32 yuan.Operating revenue jumped 71% to 1.94 billion yuan from 1.14 billion yuan in the prior year.Raytron manufactures uncooled infrared thermal imaging products. Its shares jumped 5% during the afternoon trade.
$SHA:688002
Asia
Jefferies Adjusts Perfect World's Price Target to 19.80 Yuan from 20.60 Yuan, Keeps at Buy
$SHE:002624
Asia
BP Plastics Strikes Off Dormant Unit; Shares Drop 3%
BP Plastics (KLSE:BPPLAS) unit BPPLAS Plantation has been struck off and deemed dissolved from the Companies Commission of Malaysia, according to a Monday Malaysian bourse filing.Shares fell about 3% in Tuesday's midday trade.BPPLAS Plantation was dormant with no future business plans, was dissolved as part of a cost and administrative streamlining exercise.The group said the dissolution will not have a material impact on earnings or net assets.
$KLSE:BPPLAS